Preventing HIV in South Africa: A promising new jab could replace pills

Researchers in South Africa say a new anti-HIV drug could radically slow down the spread of HIV by 2032. Lenacapavir is a twice-yearly jab that protects people from contracting the virus. But the drug is expensive and a cut in US funding may slow down its distribution. Al Jazeera’s Fahmida Miller has more from Cape Town. Subscribe to our channel: http://bit.ly/AJSubscribe Follow us on X : https://twitter.com/AJEnglish Find us on Facebook: https://www.facebook.com/aljazeera Check our website: http://www.aljazeera.com/ Check out our Instagram page: https://www.instagram.com/aljazeeraenglish/ Download AJE Mobile App: https://aje.io/AJEMobile #Lenacapavir #HIVPrevention #EndHIV #HIVAwareness #SouthAfricaHealth #GlobalHealth #HIVVaccine #USFundingCuts #TwiceYearlyJab #2032Goal #AlJazeeraEnglish